en.wikipedia.org website review
![](/include/images/menno/screenl1.png)
![](/include/images/loader.gif)
![](/include/images/pixel.png)
![](/include/images/menno/screenl2.png)
![](/include/images/loader.gif)
![](/include/images/pixel.png)
![](/include/images/loader.gif)
![](/include/images/pixel.png)
![](/include/images/menno/highlight.png)
Improve your SEO :: free trial!
en.wikipedia.org is 55% geoptimaliseerd!
SEO Keyword summary for en.wikipedia.org/wiki/cladribine
Keywords are extracted from the main content of your website and are the primary indicator of the words this page could rank for. By frequenty count we expect your focus keyword to be cladribine
Focus keyword
Short and long tail
Short Tail Keywords cladribine sclerosis multiple |
long Tail Keywords (2 words) multiple sclerosis cladribine tablets cell leukemia hairy cell giovannoni g |
long Tail Keywords (3 words) hairy cell leukemia relapsing multiple sclerosis efficacy of cladribine b c d comi g cook rammohan k rieckmann cook s rammohan |
en.wikipedia.org On-Page SEO Scan
Descriptive Elements
The <head> element of a en.wikipedia.org/wiki/cladribine page is used to inform the browser and visitors of the page about the general meta information. The head section of the page is where we place the page title, the definition of the HTML version used, the language of in which the page is written. In the head section we can also include JavaScript and CSS (markup) files for the page.
Page title
Title length
cladribine wikipedia
Meta description
Meta description legth
Meta description SEO
No meta relevance in the description detected !
Content SEO
Number of Words
Spam detected?
Headings
Heading distribution
Heading normalisation
Heading SEO impact
Emphasis (bold and italic)
Emphasis SEO impact
Images
Number of images
Images dimensions
Image alt descriptions
Images SEO impact
wikipedia free encyclopedia check edit wikidata icon wikimedia foundation powered mediawiki
Mobile SEO en.wikipedia.org/wiki/cladribine
Mobile rendering
![](/include/images/menno/screenl1.png)
![](/include/images/menno/screenl2.png)
![](/include/images/menno/highlight.png)
Mobile optimizations
Responsive design detected (mobile css)
No flash detected !
Mobile improvement
![](/include/images/icons/loader.gif)
![](/include/images/icons/loader.gif)
Marketing / lead generation for en.wikipedia.org/wiki/cladribine
Social Media
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Conversion form
Search form
Analytics
Online presence
SERP Preview
SERP Title
SERP Link
SERP Description
Domain Level SEO
Domain name
16 characters long
Domain name SEO Impact
Path name
cladribine found in path !
Structured data
Publisher Markup
Other Structured data
Website configuration
Correct processing of non-existing pages?
![](http://www.webcijfers.nl/include/images/icons/loader.gif)
Favicon icon found?
![](http://www.webcijfers.nl/include/images/icons/loader.gif)
Robots.txt found?
![](http://www.webcijfers.nl/include/images/icons/loader.gif)
Sitemap found?
![](http://www.webcijfers.nl/include/images/icons/loader.gif)
Navigation and internal links
Navigation
Url seperator
Human readable urls
Number of links
Link SEO Impact
statistics
|
en.m.wikipedia.org |
en.wikipedia.org wikimedia foundation inc
|
w view history
httpsenwikipediaorgwindexphptitlecladribineoldid1231975219
page information
printable version
sitimagene ceradenovec
|
wiki read
trade names
drugscom
medlineplus
legal status
dailymed
pregnancycategory
routes ofadministration
iv
subcutaneous
by mouth
l01
parenteral
l04
orally
multiple sclerosis
warning
pharmacokinetic
bioavailability
protein binding
metabolism
intracellular
kinases
elimination halflife
excretion
iupac name
cas number
pubchem
iupharbps
drugbank
chemspider
kegg
chebi
chembl
comptox dashboard
echa infocard
formula
molar mass
jsmol
hairy cell leukemia
bcell chronic lymphocytic leukemia
relapsingremitting multiple sclerosis
lymphocytes
nucleoside
deoxyadenosine
adenosine deaminase
deoxycytidine kinase
apoptosis
5nucleotidase
histiocytosis
erdheimchester disease
langerhans cell histiocytosis
pregnancy category d
p53
cytochrome c
ernest beutler
dennis a carson
adenosine deaminase deficiency
orphan disease
johnson johnson
new drug application
orphan drug
natural killer cells
neutrophils
myelosuppression
dangerously low levels of white blood cells
septic shock
red blood cells
anaemic
platelets
merck kgaa
cyclodextrin
european medicines agency
immunosuppressants
herpes zoster
adaptive immune system
lymphopenia
progressive multifocal leukoencephalopathy
malignancy
chemotherapy regimen
tcell prolymphocytic leukaemia
fda
health canada
pmid
s2cid
world health organization
central nervous system
signs and symptoms
ataxia
depression
diplopia
dysarthria
dysphagia
fatigue
incontinence
nystagmus
optic neuritis
pain
uhthoffs phenomenon
diagnosis of multiple sclerosis
mcdonald criteria
poser criteria
clinically isolated syndrome
expanded disability status scale
oligoclonal bands
radiologically isolated syndrome
lesional demyelinations of the central nervous system
dawsons fingers
frexalimab
management of multiple sclerosis
alemtuzumab
dimethyl fumarate
diroximel fumarate
fingolimod
glatiramer acetate
interferon beta1a
interferon beta1b
laquinimod
mitoxantrone
monomethyl fumarate
natalizumab
ocrelizumab
ozanimod
ponesimod
siponimod
teriflunomide
daclizumab
research in multiple sclerosis
autoimmune
neuromyelitis optica spectrum disorder
diffuse myelinoclastic sclerosis
mog antibody disease
chronic inflammatory demyelinating polyneuropathy
acute disseminated encephalomyelitis
balo concentric sclerosis
marburg acute multiple sclerosis
tumefactive multiple sclerosis
experimental autoimmune encephalomyelitis
hereditary
adrenoleukodystrophy
alexander disease
canavan disease
krabbe disease
metachromatic leukodystrophy
pelizaeusmerzbacher disease
leukoencephalopathy with vanishing white matter
megalencephalic leukoencephalopathy with subcortical cysts
camfak syndrome
central pontine myelinolysis
marchiafavabignami disease
mitochondrial dna depletion syndrome
list of multiple sclerosis organizations
list of people with multiple sclerosis
multiple sclerosis drug pipeline
pathophysiology
merck serono
avelumab
bisoprolol
cetuximab
efalizumab
gonadotropin preparations
human chorionic gonadotropin
levothyroxine
luteinizing hormone
metformin
saizen
serostim
tegafururacil
merck group
serono
chemotherapeutic agents
antineoplastic agents
sps
m phase
microtubule
vinca alkaloids
vinblastine
vincristine
vindesine
vinflunine
vinorelbine
taxanes
cabazitaxel
docetaxel
larotaxel
ortataxel
paclitaxel
tesetaxel
epothilones
ixabepilone
dna replication
antimetabolites
s phase
antifolate
dihydrofolate reductase inhibitor
aminopterin
methotrexate
pemetrexed
pralatrexate
thymidylate synthase inhibitor
raltitrexed
purine
adenosine deaminase inhibitor
pentostatin
halogenated
ribonucleotide reductase inhibitor
clofarabine
fludarabine
nelarabine
rabacfosadine
thiopurine
mercaptopurine
tioguanine
pyrimidine
capecitabine
carmofur
doxifluridine
floxuridine
fluorouracil
tegafur
gimeraciloteracil
dna polymerase inhibitor
cytarabine
cytarabine
gemcitabine
hypomethylating agent
azacitidine
decitabine
deoxyribonucleotide
hydroxycarbamide
topoisomerase inhibitors
camptotheca
belotecan
camptothecin
etirinotecan pegol
exatecan
irinotecan
lurtotecan
rubitecan
topotecan
podophyllum
etoposide
teniposide
intercalation
anthracyclines
aclarubicin
amrubicin
daunorubicin
doxorubicin
epirubicin
idarubicin
pirarubicin
valrubicin
zorubicin
anthracenediones
losoxantrone
pixantrone
amsacrine
bisantrene
crisnatol
menogaril
crosslinking of dna
nonclassical
nitrogen mustards
bendamustine
chlormethine
cyclophosphamide
ifosfamide
trofosfamide
chlorambucil
melphalan
melphalan flufenamide
prednimustine
uramustine
nitrosoureas
carmustine
fotemustine
lomustine
semustine
nimustine
ranimustine
streptozocin
alkyl sulfonates
busulfan
mannosulfan
treosulfan
aziridines
carboquone
thiotepa
triaziquone
triethylenemelamine
platinumbased
carboplatin
cisplatin
dicycloplatin
nedaplatin
oxaliplatin
satraplatin
altretamine
hydrazines
procarbazine
etoglucid
mitobronitol
pipobroman
triazenes
dacarbazine
mitozolomide
temozolomide
streptomyces
dactinomycin
bleomycin
mitomycins
plicamycin
photosensitizers
aminolevulinic acid
efaproxiral
methyl aminolevulinate
padeliporfin
porphyrin derivatives
porfimer sodium
talaporfin
temoporfin
verteporfin
enzyme inhibitors
tipifarnib
inhibitors
abemaciclib
alvocidib
palbociclib
ribociclib
seliciclib
bortezomib
carfilzomib
oprozomib
ixazomib
anagrelide
impdi
tiazofurin
masoprocol
parp inhibitor
fuzuloparib
niraparib
abiraterone acetate
olaparib
rucaparib
belinostat
entinostat
panobinostat
romidepsin
vorinostat
alpelisib
copanlisib
duvelisib
idelalisib
umbralisib
receptor antagonists
atrasentan
retinoid x receptor
bexarotene
sex steroid
testolactone
adagrasib
aflibercept
arsenic trioxide
asparagine depleters
asparaginase
pegaspargase
axicabtagene ciloleucel
belzutifan
brexucabtagene autoleucel
celecoxib
ciltacabtagene autoleucel
demecolcine
denileukin diftitox
eflornithine
elesclomol
elsamitrucin
enasidenib
epacadostat
eribulin
estramustine
glasdegib
idecabtagene vicleucel
imetelstat
ivosidenib
lifileucel
lonidamine
lucanthone
lurbinectedin
mitoguazone
mitotane
navitoclax
oblimersen
omacetaxine mepesuccinate
plitidepsin
retinoids
alitretinoin
tretinoin
selinexor
sotorasib
tagraxofusp
talimogene laherparepvec
tazemetostat
tebentafusp
tiazofurine
tigilanol tiglate
tisagenlecleucel
trabectedin
veliparib
venetoclax
vosaroxin
withdrawn
clinical trials
phase iii
immunosuppressive drugs
purine synthesis inhibitors
azathioprine
mycophenolic acid
dihydroorotate dehydrogenase
leflunomide
macrolides
il2
fkbp
cyclophilin
calcineurin
ciclosporin
pimecrolimus
tacrolimus
voclosporin
abetimus
gusperimus
lenalidomide
pomalidomide
thalidomide
pde4 inhibitor
apremilast
il1 receptor antagonists
anakinra
mtor
sirolimus
everolimus
ridaforolimus
temsirolimus
umirolimus
zotarolimus
antibodies
monoclonal
complement component 5
eculizumab
tnf inhibitor
adalimumab
afelimomab
certolizumab pegol
golimumab
infliximab
nerelimomab
interleukin
basiliximab
bimekizumab
briakinumab
brodalumab
canakinumab
guselkumab
ixekizumab
olokizumab
rilonacept
risankizumab
sarilumab
satralizumab
secukinumab
siltuximab
sirukumab
spesolimab
tildrakizumab
tocilizumab
ustekinumab
interleukin 5
mepolizumab
immunoglobulin e
omalizumab
interferon
faralimomab
il6
elsilimomab
il12
il23
lebrikizumab
il17a
muromonabcd3
otelixizumab
teplizumab
visilizumab
cd4
clenoliximab
keliximab
zanolimumab
cd11a
cd18
erlizumab
cd20
obinutuzumab
pascolizumab
rituximab
ublituximab
cd23
gomiliximab
lumiliximab
cd40
teneliximab
toralizumab
cd62llselectin
aselizumab
cd80
galiximab
cd147basigin
gavilimomab
cd154
ruplizumab
belimumab
bertilimumab
lerdelimumab
metelimumab
integrin
vedolizumab
interleukin6 receptor
odulimomab
il2 receptorcd25
inolimomab
tlymphocyte
zolimomab aritox
anifrolumab
atorolimumab
cedelizumab
emapalumab
fontolizumab
inebilizumab
maslimomab
morolimumab
ofatumumab
pexelizumab
reslizumab
rovelizumab
siplizumab
talizumab
telimomab aritox
teprotumumab
vapaliximab
vepalimomab
polyclonal
antithymocyte globulin
antilymphocyte globulin
fusion
ctla4
abatacept
belatacept
etanercept
alefacept
avacopan
baricitinib
blisibimod
crovalimab
danicopan
deucravacitinib
efgartigimod alfa
hyaluronidase
etrasimod
filgotinib
iptacopan
peficitinib
pegcetacoplan
ravulizumab
ritlecitinib
rozanolixizumab
sutimlimab
tofacitinib
upadacitinib
|
Links to external pages
Outloing links
cy.wikipedia.org
de.wikipedia.org
es.wikipedia.org
fa.wikipedia.org
fr.wikipedia.org
it.wikipedia.org
ja.wikipedia.org
or.wikipedia.org
ro.wikipedia.org
ru.wikipedia.org
sr.wikipedia.org
sh.wikipedia.org
uk.wikipedia.org
vi.wikipedia.org
www.wikidata.org
www.wikidata.org
commons.wikimedia.org
www.drugs.com
www.medlineplus.gov
dailymed.nlm.nih.gov
www.whocc.no
www.whocc.no
commonchemistry.cas.org
pubchem.ncbi.nlm.nih.gov
www.guidetopharmacology.org
www.drugbank.ca
www.chemspider.com
precision.fda.gov
www.kegg.jp
www.ebi.ac.uk
www.ebi.ac.uk
comptox.epa.gov
www.wikidata.org
www.wikidata.org
nctr-crs.fda.gov
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.ebs.tga.gov.au
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
web.archive.org
www.ema.europa.eu
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
hdl.handle.net
dailymed.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.nasonline.org
www.firstwordpharma.com
web.archive.org
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.fiercebiotech.com
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
web.archive.org
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.wikidata.org
aleph.nkp.cz
foundation.wikimedia.org
foundation.wikimedia.org
www.wikimediafoundation.org
SEO Advice for en.wikipedia.org
In this section we provide pointers on how you can to optimize your web page so it can be found more easily by search engines and how to make it rank higher by optimizing the content of the page itself. For each of the individual criteria the maximum score is 100%. A score below 70% is considered to be indication that the page is not complying with general SEO standards and should be evaluated and/or fixed. Not every factor is weighted the same and some are not as important as others. Relatively unimportant factors like meta keywords are not included in the overall score.
Item | Factor | Pointers | |
---|---|---|---|
PageTitle | 100% | Far too many sites lack a page title. A page title is the first thing that shows in the search results so always use the title element. | |
Title relevance | 65% | A title should reflect the contents of a site. This site has a 50 % match | |
Title Length | 30% | Limit your title to anywhere between 40 and 70 characters. Your title was 23 characters long | |
Meta Description | 0% | A meta description is the second element that shows in the search results so always use the meta description. | |
Meta description length | 0% | The meta description should be between 145 and 160 characters. This meta description is 1 characters long. | |
Meta description relevance | 0% | Meta Description should reflect the contents of a site. This site has a 0 % match | |
Number of internal links | 30% | Linking to internal pages makes pages easier to find for search engines. Try to keep the number of links on your page roughly below 100. There are 774 internal links on this page. | |
Folder structure | 100% | We found a folder structure in the links on your page. A good folder structure makes a site easier to navigate. We found 3 level 1 folders and 11 folders above or in the first level of navigation. | |
Headings | 74% | Headers should reflect the contents of a site. This site has a 32 % match | |
Links | 6% | Link anchors should to some degree reflect the contents of a site. This site has a 3 % match | |
Image alt tags | 25% | Image alt tags should to some degree reflect the contents of a site. This site has a 9 % match | |
Bold and italic | 18% | Bold and italic tags should reflect the contents of a site to some degree. This site has a 6 % match | |
Html ratio | 40% | Try to keep the html / text ratio as low as possible. More html means longer loading times. Layout should be handled in a serpate css file | |
Image descriptions | 84% | 84.210526315789 % of all images have been described via the "alt" attribute. Describing images with relevant text may lead to better results in the search engines. | |
Page errors | 100% | Pages with no errors display significantly faster on most browsers. We detected 0 errors and warnings | |
WordCount | 20% | An ideal page contains between 400 and 600 words.This page contains 5335 words | |
Server response time | 100% | A fast server speeds up a website. This server responds 81.74% faster then average | |
Gzip compression | 30% | This site does not use Gzip compression. Pages may not display as fast as they could | |
Keywords in Domainname | 30% | There are no important keywords in your domain name | |
Keywords in domain path | 100% | There are important keywords in the domain path | |
Structured Data | 100% | Structured data makes it easier for search engines to index your website | |
Inline css | 0% | Do not use inline css declarations. Inline css will slow down the rendering of the website. We detected 252 inline style declarations ( <a style="color:green">) with a size of 4922 bytes | |
Excessive use of the same words | 100% | There is no indication that there are one or more keywords that are used excessively. | |
Frames or iframes | 100% | Perfect, detected not (i)frames on your webpagina | |
Flash | 100% | Perfect, we detected no flash objects on your page | |
Css | 30% | We detected too much (2) CSS files on your page. Css files block the loading of a webpage. | |
Javascript | 100% | Perfect, we did not detect too many blocking JavaScript files | |
Mobile Website | 100% | Perfect, we found a responsive design for mobile users | |
Most important heading | 100% | Perfect, we detected a correct use of the most important (h1) heading! | |
Normalized headings | 40% | We dit not font a normalized heading structure. A heading 2 (h2) for example should be followed by a heading of an equal level (h2), a child heading (h3) or even a aprent heading (h1). |
How would you like to have SEO advice for all your pages ?? Start your SEO Dashboard and optimize your website!
en.wikipedia.org images and descriptions
10 images found at en.wikipedia.org Images can improve the user experience for a website by making a pag visually appealing Images can also add extra keyword relevance to a webpage by using alt tags. Images can also slow down a website. If the width and height for a picture is not specified for a browser know in advance how large the image is. A browser must first load the picture and see before it knows how much space should be on the page. Upon reservation In the meantime, the browser can do little but wait. When the height and width for the plate are given in the HTML code, a browser just continues to build for a page while the images load in the background.
http://en.wikipedia.org/static/images/icons/wikipedia.png height: 50 width: 50 description: no alt description found |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-wordmark-en.svg height: height attribute not set width: width attribute not set description: wikipedia |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-tagline-en.svg height: 13 width: 117 description: the free encyclopedia |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/7/7a/cladribine.svg/200px-cladribine.svg.png height: 177 width: 200 description: no alt description found |
|
https://upload.wikimedia.org/wikipedia/en/thumb/f/fb/yes_check.svg/7px-yes_check.svg.png height: 7 width: 7 description: check |
|
https://upload.wikimedia.org/wikipedia/en/thumb/8/8a/oojs_ui_icon_edit-ltr-progressive.svg/10px-oojs_ui_icon_edit-ltr-progressive.svg.png height: 10 width: 10 description: edit this at wikidata |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/who_rod.svg/8px-who_rod.svg.png height: 19 width: 8 description: icon |
|
https://login.wikimedia.org/wiki/special:centralautologin/start?type=1x1 height: 1 width: 1 description: no alt description found |
|
http://en.wikipedia.org/static/images/footer/wikimedia-button.svg height: 29 width: 84 description: wikimedia foundation |
|
http://en.wikipedia.org/static/images/footer/poweredby_mediawiki.svg height: 29 width: 84 description: powered by mediawiki |
How are images contributing to your SEO site-wise ? Your leading content tool has the awnsers!